Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia

Brain Stimulation
Vivek H PhutaneBangalore N Gangadhar

Abstract

Several studies show that bifrontal electrode placement produces relatively fewer cognitive adverse effects than bitemporal placement during electroconvulsive therapy (ECT) in depression. There are no reports comparing these electrode placements in schizophrenia. This study compared the clinical and cognitive effects of bifrontal and bitemporal electrode placements in schizophrenia patients referred for electroconvulsive therapy (ECT). 122 schizophrenia patients who were prescribed ECT were randomized to receive ECT with either bifrontal (BFECT; n = 62) or bitemporal (BTECT; n = 60) placement. Their concomitant anti-psychotic medications and the number of ECT sessions were not controlled. Psychopathology was assessed using the Brief Psychiatric Rating Scale (BPRS), Bush-Francis Catatonia Rating Scale (BFCRS), and the Nurse Observation Scale for Inpatient Evaluation (NOSIE). Cognitive functions were assessed 24-h after the final ECT using a battery of tests. Clinical improvement was compared using chi-square test, repeated measures ANOVA and analysis of covariance (ANCOVA). Cognitive adverse effects were compared using t-test. At the end of 2 weeks (after 6 ECT sessions) 63% and 13.2% of BFECT and BTECT patients respectively had...Continue Reading

References

May 1, 1990·Psychological Medicine·J S LawsonF J Letemendia
Jun 30, 1988·The New England Journal of Medicine·A LaupacisR S Roberts
May 1, 1973·The British Journal of Psychiatry : the Journal of Mental Science·R Abrams, M A Taylor
Jul 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·A I Scott
May 1, 1993·Psychological Medicine·F J LetemendiaD W Lywood
Jan 1, 1996·Clinical EEG (electroencephalography)·E Niedermeyer
Jan 5, 2000·The American Journal of Psychiatry·S H BailineS Pollack
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Jul 10, 2002·Journal of Affective Disorders·E S M SaravananD K Subbakrishna
Sep 2, 2003·NeuroImage·Hal BlumenfeldI George Zubal
Nov 1, 2003·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·A T DugbarteyR K Mahurin
Jan 31, 2004·Epilepsy & Behavior : E&B·Kelly A McNally, Hal Blumenfeld
May 29, 2004·The Journal of ECT·Worrawat Chanpattana, Barry Alan Kramer
May 21, 2005·The Journal of ECT·Worrawat ChanpattanaB N Gangadhar
Aug 30, 2005·The Journal of ECT·Worrawat ChanpattanaRungrueng Kitphati
Apr 23, 2008·Social Psychiatry and Psychiatric Epidemiology·Omer Saatcioglu, Nesrin B Tomruk
Jul 29, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Gábor GazdagGábor Sándor Ungvari
Apr 28, 2009·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Paul MaruffRobert H Pietrzak
May 16, 2009·The Journal of ECT·Worrawat ChanpattanaChittaranjan Andrade
Mar 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Charles H KellnerGeorgios Petrides
Sep 30, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Mahesh MahadevaiahBangalore N Gangadhar
May 12, 2011·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Lambros MessinisPanagiotis Papathanasopoulos
Jul 21, 2011·Indian Journal of Psychiatry·Vivek H PhutaneB N Gangadhar

❮ Previous
Next ❯

Citations

Dec 25, 2012·Psychiatry Research·Hulegar A AbhishekhBangalore N Gangadhar
Jul 21, 2011·Indian Journal of Psychiatry·K MuralidharanS Jain
Apr 5, 2014·Indian Journal of Psychological Medicine·Hulegar A AbhishekhBangalore N Gangadhar
Sep 30, 2014·Psychosomatics·Nina GonzalesWilliam Rayburn
Mar 19, 2013·Schizophrenia Research·Maurizio PompiliPaolo Girardi
Dec 3, 2014·Asian Journal of Psychiatry·Preeti JacobJohn Vijay Sagar
Jun 14, 2013·Clinical EEG and Neuroscience·Gopalkumar RakeshBangalore N Gangadhar
Mar 13, 2018·Current Opinion in Psychiatry·Sohag N SanghaniCharles H Kellner
Feb 11, 2015·The Journal of Nervous and Mental Disease·Agnieszka PawełczykJolanta Rabe-Jabłońska
Jun 24, 2017·European Archives of Psychiatry and Clinical Neuroscience·Arnaud LeroyAli Amad
Apr 27, 2019·Psychiatry and Clinical Neurosciences·Christopher Yi Wen ChanPhern Chern Tor
Dec 7, 2018·Acta Neuropsychiatrica·Sandeep GroverRaman Koirala
Jul 3, 2020·Indian Journal of Psychological Medicine·Jagadisha ThirthalliGirish Kunigiri
Jul 23, 2020·Journal of Affective Disorders·Ravi K SharmaJagadisha Thirthalli
Feb 27, 2021·Journal of Affective Disorders·Xiao Wei TanColleen Loo
Apr 15, 2021·Psychiatry and Clinical Neurosciences·Yuxi WangKai Hong Tay
May 26, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Phern Chern TorColleen Loo
Jun 14, 2019·Molecular Neuropsychiatry·Sana A AliRaphael J Braga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Catatonia

Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.